<DOC>
	<DOCNO>NCT00888095</DOCNO>
	<brief_summary>The aim study analyze effect two different target deep brain stimulation : caudal Zona incerta Nucleus subthalamicus . The present study investigate effect DBS use blind , randomize stratified design patient Parkinson 's disease .</brief_summary>
	<brief_title>Deep Brain Stimulation ( DBS ) For Parkinson 's Disease : Caudal Zona Incerta Versus Subthalamic Nucleus</brief_title>
	<detailed_description>Parkinson 's Disease ( PD ) severe neurological movement disorder comprise triad symptom bradykinesia , rigidity tremor . It effectively treat dopaminergic replacement therapy early course disease ; however , 5-10 year medical therapy insufficient majority patient . Since early 90 implantation electrode Nucleus subthalamicus ( STN ) , ( deep brain stimulation ; DBS ) establish . DBS PD- patient provide definite longlasting relief motor symptom impair quality life compare optimized medical treatment ( Deuschl et al . 2006 ) . Conventionally , electrodes implanted STN target pedunculopontine nucleus Zona incerta ( ZI ) report useful . Importantly , ZI key role connection loop basal ganglion , thalamic region cortex . Retrospective study DBS-treated patient show relief symptom DBS- treat PD patient , contact electrodes locate ZI ( Voges et al. , 2002 ; Hamel et al. , 2003a , 2003b ) . However , prospective randomize study analyse effect bilateral DBS compare target caudal ZI ( cZI ) STN available . Therefore , present study investigate effect tolerance DBS target blind , randomize stratify design total 70 PD patient ( see inclusion end exclusion criterion ) . The impairment movement quality life assess via establish scale . Effects , tolerance side effect DBS monitor closely re-assessed period twelve month . Primary study criterion include UPDRS-III quality life .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's disease ( criteria British Brain Bank : LDOPA Apomorphinsensitivity 30 % typical Parkinsonian tremor rest ) duration disease &gt; 18 month age 18 75 Jahren relevant disablement daily activities/ impairment despite medical mental therapy inform signed consent patient major depression suicidal thought ( Becks Depressions InventoryScore &gt; 25 ) ; depression past exclusion criterion Mattis Dementia Rating Scalescore &lt; 130 stereotactic brain operation past significant brain atrophy increase bleeding tendency reduce infection defense relevant cerebrovascular disease acute psychosis ( benign and/or hallucination past exclusion criterion ) physical and/or mental illness likely affect study procedure negative way ( e.g. , cancer reduce life expectancy ) abuse drug alcohol female study participant child bear age without adequate contraception woman pregnancy lactation sufficient knowledge German language answer questionnaires surgical contraindication participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>deep brain stimulation</keyword>
	<keyword>caudal Zona incerta</keyword>
	<keyword>Nucleus subthalamicus</keyword>
	<keyword>Parkinson 's disease</keyword>
	<keyword>randomize</keyword>
	<keyword>blind</keyword>
	<keyword>Movement disorder</keyword>
</DOC>